Victory Capital Management’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
DC
VCM
OFM
LCM
DFO
Victory Capital Management's NUVB Position: Q1 2026 in Review
Victory Capital Management increased its Nuvation Bio (NUVB) stake by 1.2% in Q1 2026, buying an estimated $1.78K and bringing the position to 27,882 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #2259.
Victory Capital Management first reported a position in NUVB in Q1 2021 and has held it in 19 quarters since. The position peaked at $2.12M in Q1 2021. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.
- Victory Capital Management held 27,882 shares of Nuvation Bio worth $120K as of Q1 2026.
- Victory Capital Management bought 319 Nuvation Bio shares in Q1 2026, an estimated $1.78K.
- Nuvation Bio made up ﹤0.01% of Victory Capital Management's portfolio in Q1 2026, its #2259 holding.
- Victory Capital Management first reported a position in Nuvation Bio in Q1 2021 and has held it in 19 quarters since.
- Victory Capital Management's Nuvation Bio position peaked at $2.12M in Q1 2021.
- 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.
Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.